Gelesis Inc To Discuss Definitive Business Combination Agreement With PureTech Health PLC And Capstar Special Purpose Acquisition Corp Call Transcript
Welcome to the Gelesis and Capstar Transaction Conference Call. We would like to first remind everyone that this call may contain forward-looking statements that are not historical facts, consistent with the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995.
I will now turn the call over to Mr. Steve Hicks, Chairman and CEO of Capstar.
Thank you for joining us today. I'm Steve Hicks, and with me today is Clayton Christopher. We're very happy to introduce you to Gelesis' Yishai Zohar the Founder and CEO. We've gotten to know Yishai and his team over the last few months and have been very impressed with him, his team and the business that he has built.
When we set out with our IPO in July of 2020, we told you that we were looking for a high-growth consumer and healthcare-oriented business that was disrupting a large addressable market, and now we found that with Gelesis. We're a unique partner for Gelesis because of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |